Hyaluronic acid facilitates glioma cell invasion in vitro

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2917-2922

  Nakagawa, Takao ^a   Kubota, Toshihiko ^a   Kabuto, Masanori ^a   Kodera, Toshiaki ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Glioma; Hyaluronic acid; Hyaluronidase; Invasion; Proteinase

Indexed keywords

HYALURONIC ACID; HYALURONIDASE; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; PROTEINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL SPREADING; CONTROLLED STUDY; ENZYME RELEASE; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CELL ADHESION; CELL DIVISION; CELL MOVEMENT; GELATINASES; GLIOMA; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 0029964853     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pilkington GJ: Tumour cell migration in the central nervous system. Brain Pathol 4: 157-166, 1994.
2. Paulus W, Tonn JC: Interactions of glioma cells and extracellular matrix. J Neurooncol 24: 87-91, 1995.
3. Nakagawa T, Kubota T, Kahuto M, Fujimoto N, Okada Y: Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: Implications of the growth and cellular invasion of the extracellular matrix. J Neurooncol 28: 13-24, 1996.
4. Rutka JT, Apodaca G, Stern R, Rosenblum M: The extracellular matrix of the central and peripheral nervous systems: Structure and function. J Neurosurg 69: 155-170, 1992.
5. Burger PC, Heintz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68: 698-704, 1988.
6. Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta LA, Sawaya R: Role of plasminogen activator and of 92-kDa type IV collagenase in glioblastoma invasion using an in vitro Matrigel model. J Neurooncol 18: 129-138, 1994.
7. Giese A, Loo MA, Rief MD, Tran N, Berens ME: Substrates for astrocytoma invasion. Neurosurgery 37: 294-302, 1995.
8. Koochekpour S, Pilkington GJ, Merzak A: Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 63: 450-454, 1995.
9. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ: Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329, 1990.
10. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M: Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12: 296-304,1994.
11. Rutka JT, Matsuzawa K, Hubbard SL, Furuyama K, Becker LE, Stetler-Stevenson W, Edwards DR, Dirks PB: Expression of TIMP-1, TIMP-2. 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Oncol 6: 877-884, 1995.
12. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77, 1994.
13. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995.
14. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oda K, Rao VH, Tomonaga M, Nicolson GL, Rao JS: Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54: 3656-3661, 1994.
15. Rutka JT, Giblin JR, Apodaca G, DeArmond SJ, Stern R, Rosenblum ML: Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins. Cancer Res 47: 3515-3522, 1987.
16. Albini A, Iwamoto Y, Kleinman K, Martin GR, Aaronson SA, Rozlowski JM and Mcewan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
17. Imamura H, Takao S, and Aikou T: A modified invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion. Cancer Res 54: 3620-3624, 1994.
18. Heussen C and Dowdle EB: Electrophoretic analysis plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196-202, 1980.
19. Hotez PJ, Narasimhan S, Haggerty J, Milstone L, Bhopale V, Schad GA, and Richards FF: Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans. Infect Immun 60: 1018-1023, 1992.
20. Toole BP, Biswas C, Gross J: Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 76: 6299-6303, 1979.
21. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111: 2765-2774, 1990.
22. Yang B, Zhang L, Turley EA: Identification of two hyaluronanbinding domains in the hyaluronan receptor RHAMM. J Biol Chem 268: 8617-8623, 1993.
23. Banerjee SD, Toole BP: Monoclonal antibody to chick embryo hyaluronan-binding protein: changes in distribution of binding protein during early brain development. Dev Biol 146: 186-197, 1991.
24. Yoneda M, Suzuki S, Rimata R: Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein. J Biol Chem 265: 5247-5257, 1990.
25. Asher R, Bignami A: Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203: 80-90, 1992.
26. Merzak A, Roocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988-3992, 1994.
27. Ruppner MC, Van Meir E, Gauthier Th, Hamou M-F, De Tribolet N: Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50: 572-577, 1992.
28. Nagasaka S, Tanabe RR, Bruner JM, Saya H, Sawaya RE, Morrison RS: Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82: 858-863, 1995.
29. Gatley CL, Muul LM, Greenwood MA, Papazoglou S, Dick SJ, Rornblith PL, Smith BH, Gatley MR: In vitro studies on the cellmediated immunoresponse to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack. J Immunol 133: 3387-3395, 1984.
30. Rooney P, Rumar S, Ponting J, Wang M: The role of hyaluronan in tumor neovascularization. Int J Cancer 60: 632-636, 1995.